Log in to your Inderes Free account to see all free content on this page.
Newbury Pharmaceuticals
1.16 SEK
+0.87 %
Less than 1K followers
NEWBRY
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+0.87 %
-25.48 %
-56.25 %
-58.60 %
-67.19 %
-66.23 %
-81.78 %
-
-90.83 %
Newbury Pharmaceuticals is a pharmaceutical company. The company develops a pipeline of in-house developed and licensed products with a focus on specialty drugs in areas such as oncology, rare diseases, and neurology. The company conducts its business within the Scandinavian market. Newbury Pharmaceuticals was founded in 2020 and has its headquarters in Lund.
Read moreMarket cap
35.11M SEK
Turnover
201.28K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
14.1.
2026
General meeting '26
21.1.
2026
Interim report Q1'26
15.4.
2026
Interim report Q2'26
All
Webcasts
Press releases
ShowingAll content types
Kallelse till årsstämma i Newbury Pharmaceuticals AB
Nordic Market Update
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio